The data were featured today in a spotlight poster presentation at the 2024 San Antonio Breast Cancer Symposium (SABCS). The poster is now ...
News
- ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at ...
- US appeals court rejects Nasdaq's diversity rules for company boards - MySA
Official Inspection Station in San Antonio is one of many companies feeling the effects of the ... biotech and industrial companies as well.
- Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ...
Gonzalez Convention Center in San Antonio, Texas. . The poster presents ... Celcuity is a clinical-stage biotechnology company focused on ...
- Director Harmon Cyrus was granted 29,250 shares and sold $147,956 worth of ... - Quantisnow
... San Antonio Breast Cancer Symposium (SABCS) in December Strong cash ... Biotechnology: Pharmaceutical Preparations. Health Care. Medical/Nursing ...
- LYNPARZA® (olaparib) demonstrated clinically meaningful prolonged survival benefit ... - BioSpace
These results were presented today at the San Antonio Breast Cancer ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.